asxan.ai Agents Hub

Skin Beauty

Evidence Stack

Dermal matrix · moisture · elasticity · antioxidant capacity

Evidence-first skin-beauty stack — what the human-evidence record actually shows for the ingredients most associated with skin moisture, elasticity, and photoprotection, including the honest nulls (astaxanthin wrinkle-depth, oral vitamin E skin endpoints). This is mechanism and evidence mapping, not medical advice. Anyone with a diagnosed dermatologic condition should follow a dermatologist's treatment plan. All PubMed identifiers are verified against PubMed before inclusion; cross-market regulatory claims appear verbatim per their authorising authority (FDA · EFSA · ANVISA · TGA).

Last reviewed · How we assess evidence →

Quick Summary

  • Astaxanthin skin moisture and elasticity is meta-analytically supported; wrinkle-depth reduction is NOT. Zhou 2021 (PMID 34578794) meta-analysis of 11 RCTs reported significant pooled effects on skin moisture and elasticity at 4–12 mg/day for 4–16 weeks; pooled wrinkle-depth reduction was NOT significant. The honest framing: moisture and elasticity yes, wrinkle reversal no. See /ingredients/astaxanthin/.
  • Collagen peptides have robust meta-analytic signal for skin elasticity and hydration at 2.5–10 g/day. de Miranda 2021 (PMID 33742704) skin parameters meta-analysis supports elasticity, hydration, and (modestly) wrinkle signals across 8–12 week trials; Proksch 2014 (PMID 23949208) is the foundational single RCT. Molecular-weight (~2–5 kDa) and peptide-profile heterogeneity is the dominant interpretive caveat — cross-product extrapolation is not warranted.
  • Oral hyaluronic acid supports skin moisture at the 12-week horizon. Kawada 2014 (PMID 25014997) Nutr J RCT supports moisturizing effect on dry skin; Oe 2017 (PMID 28761365) double-blind placebo-controlled RCT at 12 weeks reported wrinkle relief on crow's-feet area in oral HA cohort. Long-term beyond 12 weeks is limited.
  • Dietary lycopene contributes endogenous photoprotection — NOT a sunscreen substitute. Stahl 2001 (PMID 11340098) — 10 weeks of dietary tomato paste (~16 mg lycopene/day) increased the minimal erythema dose (MED) ~33%. This is real, modest, endogenous photoprotection; it does NOT substitute for topical sunscreen, sun-avoidance behavior, or UPF clothing.
  • Oral vitamin E (tocopherols) skin-endpoint RCT evidence is thin. Vitamin E biochemistry as a lipid-membrane antioxidant is settled, but isolated oral vitamin E RCTs for skin wrinkle / elasticity / hydration outcomes in already-replete adults are preliminary / emerging here — included as honest reference context, not as a robust skin-beauty claim.
  • This is not medical advice. The signals on this page are for skin moisture, elasticity, and (modestly) wrinkle parameters in generally healthy adults — they are NOT treatments for atopic dermatitis, psoriasis, acne, rosacea, or any diagnosed skin condition. Anyone with a diagnosed dermatologic condition should follow a dermatologist's treatment plan.

The Evidence Stack

The "evidence" column below describes the strength and direction of the outcome evidence in qualitative terms — well-established, robust, moderate/mixed, preliminary/emerging, or null/negative. The S/A/B/C tier that grades how extensively an ingredient is studied (its evidence volume) lives on each linked ingredient page, not here.

Ingredient Skin evidence (qualitative) Key Trial / Meta-analysis asxan.ai page
Astaxanthin Robust for skin moisture + elasticity (meta-analytic pooled significant); null/negative for wrinkle-depth (pooled non-significant) Zhou 2021 PMID 34578794 (meta · 11 RCTs · moisture + elasticity pooled significant; wrinkle pooled NS); Tominaga 2012 PMID 22428137 (RCT cosmetic benefits all skin layers); Liu 2024 PMID 38243785 (fatigue / motor cross-system meta) /ingredients/astaxanthin/
Collagen Peptides Robust for skin elasticity + hydration (meta-analytic); modest for wrinkle signal — product-heterogeneity caveat de Miranda 2021 PMID 33742704 (skin parameters meta-analysis); Proksch 2014 PMID 23949208 (foundational elasticity RCT 2.5 g/day for 8 weeks); Bello 2006 PMID 17076983 (broader hydrolysate review · joint context) /ingredients/collagen-peptides/
Hyaluronic Acid (oral) Moderate / mixed — 12-week hydration and wrinkle RCT signals; long-term beyond 12 weeks limited Kawada 2014 PMID 25014997 (RCT · oral HA dry-skin moisturizing · Nutr J); Oe 2017 PMID 28761365 (12-week DBPC RCT · wrinkle relief on crow's feet · Clin Cosmet Investig Dermatol) /ingredients/hyaluronic-acid/
Lycopene Moderate / mixed — endogenous photoprotection (MED ~33% at 10 wk); modest magnitude, not a sunscreen substitute Stahl 2001 PMID 11340098 (RCT · dietary tomato paste 16 mg lycopene/day for 10 weeks · MED elevation · J Nutr); Stahl 2002 review PMID 12239422 (carotenoids and solar UV protection · Skin Pharmacol Appl Skin Physiol) /ingredients/lycopene/
Tocopherols (Vitamin E) Preliminary / emerging — biochemistry settled, but oral skin-endpoint RCT evidence thin in non-deficient adults Oral skin-endpoint meta-analytic evidence not in hand at this time — included as reference / negative-honest context · see "What the Trials Show" /ingredients/tocopherols/

How It Works

Each ingredient engages skin biology by a different route — astaxanthin as a lipophilic membrane ROS scavenger, collagen peptides as fibroblast-stimulating dermal-matrix substrate, oral hyaluronan via a debated absorption pathway, and lycopene as an accumulating endogenous UV-photoprotection antioxidant.

Astaxanthin — lipophilic ROS scavenging and the moisture/elasticity signal. Astaxanthin partitions across the lipid bilayer (its molecular architecture spans both polar and non-polar regions of the membrane) and is one of the most efficient lipophilic radical scavengers known. Zhou 2021 (PMID 34578794) meta-analysis of 11 RCTs reported significant pooled effects on skin moisture and elasticity at 4–12 mg/day for 4–16 weeks; pooled wrinkle-depth reduction did NOT reach significance. Tominaga 2012 (PMID 22428137) is a representative single RCT signal of cosmetic benefit across all skin layers (corneocyte / epidermis / basal / dermis). The honest framing: moisture and elasticity yes; wrinkle reversal no. See /ingredients/astaxanthin/ for the full mechanism narrative.

Collagen peptides — fibroblast stimulation, matrix substrate, and the peptide-profile heterogeneity caveat. Hydrolyzed collagen supplies small di- and tri-peptides (hydroxyproline-containing; Pro-Hyp, Gly-Pro-Hyp) that have been measured in plasma after oral dosing. The proposed mechanism involves fibroblast stimulation and matrix substrate provision in the dermis. de Miranda 2021 (PMID 33742704) meta-analysis supports skin elasticity, hydration, and (modestly) wrinkle signals across 2.5–10 g/day, 8–12 week trials; Proksch 2014 (PMID 23949208) at 2.5 g/day for 8 weeks is the most-cited foundational RCT. Molecular-weight (~2–5 kDa) and peptide-profile heterogeneity is the dominant interpretive caveat — cross-product extrapolation across different collagen peptide preparations is not warranted.

Oral hyaluronic acid — absorption pathway debate and the 12-week moisture / wrinkle signal. Oral low-molecular-weight HA (typically <50 kDa) has measured plasma appearance after oral dosing, but the connective-tissue distribution and dermal incorporation pathway remains mechanistically debated — proposed routes include gut microbial degradation to oligosaccharides followed by absorption and incorporation, or direct low-MW HA absorption. Kawada 2014 (PMID 25014997) Nutr J RCT supports moisturizing effect on dry skin; Oe 2017 (PMID 28761365) 12-week DBPC RCT reported wrinkle relief on the crow's-feet area in the oral HA cohort. Long-term RCT evidence beyond 12 weeks remains limited.

Lycopene and the endogenous photoprotection MED signal. Lycopene is a tomato-derived carotenoid that accumulates in skin over weeks of dietary or supplemental intake and contributes to endogenous antioxidant capacity in skin against UV-induced ROS. Stahl 2001 (PMID 11340098) reported sustained dietary tomato paste intake (~16 mg lycopene/day) increased the minimal erythemal dose (MED — the UV dose required to produce visible skin erythema) ~33% at 10+ weeks. Stahl 2002 review (PMID 12239422) extends the framework across carotenoids and solar UV protection. This is a real, modest, endogenous photoprotection signal — NOT a substitute for topical sunscreen.

Vitamin E — biochemistry settled, oral skin-endpoint RCT thin. Vitamin E (α-tocopherol) is biochemically established as a lipid-membrane antioxidant; tocotrienol biology is adjacent. However, oral vitamin E RCT evidence for specific skin-endpoint (wrinkle, elasticity, hydration) outcomes in non-deficient adults is thin in the meta-analytic record. The supportable framing is preliminary / emerging; it is included on this page as honest reference context rather than as a robust skin-beauty claim.

Body systems engaged: Skin & Connective Tissue. Mechanism tags: Collagen synthesis · Free radical scavenging · Carotenoid bioavailability.

What the Trials Show — Including the Nulls

Collagen peptide cross-product extrapolation is NOT warranted. The de Miranda 2021 (PMID 33742704) meta-analysis signal is built on heterogeneous collagen peptide preparations differing in molecular weight (~2–5 kDa range), peptide profile, source species, and hydrolysis method. Extrapolating from one commercial product's RCT signal to another differently-prepared product is methodologically unsound; collagen peptide products are NOT interchangeable.

Oral hyaluronic acid does NOT have long-term endpoint RCT evidence beyond 12 weeks. Kawada 2014 (PMID 25014997) and Oe 2017 (PMID 28761365) anchor 12-week trial windows. The connective-tissue distribution / dermal incorporation pathway of oral HA is mechanistically debated; whether long-term oral HA produces durable structural change in dermal HA content is not RCT-established.

Lycopene is NOT a topical sunscreen substitute. Stahl 2001 (PMID 11340098) reported ~33% MED elevation from 10 weeks of dietary tomato paste — this is real, modest, endogenous photoprotection but is NOT equivalent in magnitude or reliability to broad-spectrum SPF 30+ topical sunscreen. Anyone with elevated skin-cancer risk, photosensitivity, or extended sun exposure should rely on topical sunscreen, sun-avoidance behavior, and UPF clothing — NOT dietary lycopene as a primary photoprotection strategy.

Oral vitamin E (tocopherols) skin-endpoint RCT evidence is thin in non-deficient adults. Vitamin E biochemistry as a lipid-membrane antioxidant is settled, and topical vitamin E has photoprotection adjacency (particularly in combination with topical vitamin C). However, oral vitamin E RCTs for specific skin-endpoint (wrinkle / elasticity / hydration) outcomes in already-replete adults do NOT robustly reach a meta-analytic threshold. Generic high-dose oral vitamin E is NOT a supported skin-beauty stack component on this page — it is included as preliminary / emerging reference context.

Stacking & Timeline

Mechanistic pairings are plausible but rarely backed by head-to-head synergy trials; realistic timelines run from weeks (collagen elasticity, lycopene MED) to a lifetime (cumulative sun-protection behavior as the photoaging substrate).

Mechanistic pairs

Astaxanthin + Collagen Peptides · moisture-elasticity-structure pair. Astaxanthin (Zhou 2021 PMID 34578794) anchors the moisture and elasticity signal via lipophilic ROS scavenging; collagen peptides (de Miranda 2021 PMID 33742704) anchor the dermal matrix substrate / fibroblast stimulation mechanism. The two mechanisms are non-redundant and complementary; direct head-to-head pair-RCT trials in this specific combination are limited, but mechanism rationale supports the layering.

Oral HA + Sustained 12-week Dosing · threshold pair (dose × duration). Kawada 2014 (PMID 25014997) and Oe 2017 (PMID 28761365) both anchor 12-week trial windows for skin moisture and wrinkle endpoints. Sub-12-week durations have NOT consistently reproduced the moisturizing / wrinkle signal — duration matters for the clinical-endpoint claim.

Lycopene + Topical Sunscreen + UPF clothing · layered photoprotection framework. Stahl 2001 (PMID 11340098) ~33% MED elevation from 10 weeks of dietary tomato paste integrates as a modest endogenous layer on TOP of topical SPF 30+ sunscreen and UPF clothing — NOT as a substitute. The honest framework: lycopene contributes a small additional layer to a broader sun-protection strategy.

Astaxanthin + Healthy-Aging Cross-System Context. Astaxanthin Zhou 2021 (PMID 34578794) skin meta + Liu 2024 (PMID 38243785) fatigue / motor meta + Xia 2020 (PMID 32755613) cardiovascular meta represent a healthy-aging cross-system signal cluster. The skin-beauty rationale layers onto a broader astaxanthin healthy-aging context; see Senior 60+.

When to see results — realistic timeframes

8 weeks · collagen peptide skin elasticity (foundational RCT window). Proksch 2014 (PMID 23949208) at 2.5 g/day for 8 weeks is the foundational single RCT window for elasticity gain. de Miranda 2021 (PMID 33742704) meta-analytic pooled trials predominantly 8–12 weeks.

8–16 weeks · astaxanthin skin moisture and elasticity (meta-analytic window). Zhou 2021 (PMID 34578794) meta-analysis pooled trials predominantly 4–16 weeks at 4–12 mg/day; the significant moisture and elasticity pooled effects typically emerge by week 8–12.

10 weeks · lycopene MED elevation (Stahl protocol window). Stahl 2001 (PMID 11340098) — 10 weeks of dietary tomato paste (~16 mg lycopene/day) for the ~33% MED elevation signal. Lycopene serum accumulation requires weeks of consistent intake; acute single-dose photoprotection is NOT the relevant framework.

12 weeks · oral hyaluronic acid moisture and wrinkle endpoint (Kawada / Oe protocol window). Kawada 2014 (PMID 25014997) and Oe 2017 (PMID 28761365) both anchor 12-week trial durations for moisturizing and wrinkle-relief endpoints. Beyond 12 weeks is the open question — long-term RCT data limited.

Lifetime · sun-protection behavior as the cumulative photoaging substrate. Photoaging is overwhelmingly a function of cumulative UV exposure over decades. Dietary lycopene / oral supplementation in adulthood is layered on top of lifetime sun-protection behavior (topical sunscreen, sun-avoidance, UPF clothing) — NOT a replacement for it.

Frequently Asked Questions

1. Does astaxanthin actually reverse wrinkles?

No — the pooled meta-analytic wrinkle-depth reduction signal did NOT reach significance. Zhou 2021 (PMID 34578794) meta-analysis of 11 RCTs reported significant pooled effects on skin moisture and elasticity at 4–12 mg/day for 4–16 weeks, but pooled wrinkle-depth reduction was NOT significant. The honest framing: astaxanthin supports moisture and elasticity, not wrinkle reversal. Tominaga 2012 (PMID 22428137) is a representative single RCT signal of cosmetic benefit across all skin layers.

2. Are all collagen peptide products interchangeable?

No — collagen peptide products differ substantially in molecular weight (~2–5 kDa range), peptide profile, source species, and hydrolysis method. de Miranda 2021 (PMID 33742704) meta-analysis is built on heterogeneous preparations. Cross-product extrapolation from one commercial RCT signal to another differently-prepared product is methodologically unsound. When choosing a collagen peptide product, look for clinical trial evidence on that specific preparation (or a closely matched one) rather than relying on the meta-analytic signal in the abstract.

3. Does oral hyaluronic acid actually work for skin?

Yes — at 12-week horizons. Kawada 2014 (PMID 25014997) Nutr J RCT supports moisturizing effect on dry skin; Oe 2017 (PMID 28761365) 12-week double-blind placebo-controlled RCT at oral HA 120 mg/day reported wrinkle relief on the crow's-feet area. The mechanistic question of how oral HA reaches the dermis (gut microbial degradation to oligosaccharides → absorption / incorporation, or direct low-MW absorption) is still debated; the clinical signal at 12 weeks is supported. Long-term beyond 12 weeks is the open question.

4. Can dietary lycopene replace sunscreen?

No — absolutely not. Stahl 2001 (PMID 11340098) reported ~33% MED elevation from 10 weeks of dietary tomato paste (~16 mg lycopene/day). This is real, modest, endogenous photoprotection but is NOT equivalent in magnitude or reliability to broad-spectrum SPF 30+ topical sunscreen. Anyone with elevated skin-cancer risk, photosensitivity, fair skin, or extended sun exposure should rely on topical sunscreen + sun-avoidance + UPF clothing. Lycopene is a small additional layer, not a primary photoprotection strategy.

5. Should I take oral vitamin E for my skin?

The oral vitamin E RCT evidence for specific skin-endpoint outcomes (wrinkle / elasticity / hydration) in non-deficient adults is thin — it is preliminary / emerging, not robust. Vitamin E biochemistry as a lipid-membrane antioxidant is settled and topical vitamin E (particularly in combination with topical vitamin C) has photoprotection adjacency. But oral vitamin E supplementation in already-replete adults is NOT a strongly supported skin-beauty stack component on the current evidence base; it is included on this page as honest reference context, not a robust recommendation.

6. How long do I need to take these for results?

The realistic time frames anchored on RCT evidence: 8 weeks for collagen peptide elasticity (Proksch 2014 PMID 23949208), 8–16 weeks for astaxanthin moisture and elasticity (Zhou 2021 PMID 34578794 meta), 10 weeks for lycopene MED elevation (Stahl 2001 PMID 11340098), 12 weeks for oral HA moisture and wrinkle (Kawada 2014 PMID 25014997 / Oe 2017 PMID 28761365). If a product promises "results in days," that promise is not aligned with the published RCT evidence.

7. Why does this stack list vitamin E if its skin RCT evidence is thin?

Because honest evidence mapping includes the preliminary / emerging cases, not just the robust ones. Vitamin E's lipid-membrane antioxidant biochemistry is settled and it is frequently positioned for skin, so the page addresses it directly rather than omitting it — and discloses that oral vitamin E does NOT robustly reach a meta-analytic skin-endpoint threshold in non-deficient adults. It is reference context, not a robust claim.

References

All PMIDs verified against PubMed. Effect sizes are reported as published. Each citation is checked against the PubMed record (first author, year, title, and journal) before it is published.

Citation corrections. Several citations were corrected to their verified PubMed records: Kawada 2014 oral hyaluronan to PMID 25014997 (an earlier PMID 25320391 indexed a 2014 veterinary paper); Oe 2017 to PMID 28761365 (an earlier PMID 28761986 indexed a 2018 smoking paper); Stahl 2001 lycopene to PMID 11340098 (an earlier PMID 11293480 indexed a 2001 fungal-PCR paper); and Tominaga 2012 astaxanthin to PMID 22428137 (an earlier PMID 23107346 indexed a 2012 theanine paper).

  1. PMID 34578794 · Zhou 2021 · astaxanthin skin meta-analysis (11 RCTs · 4–12 mg/day · 4–16 wk) · moisture + elasticity pooled significant; wrinkle-depth pooled NOT significant
  2. PMID 22428137 · Tominaga 2012 · Acta Biochim Pol · "Cosmetic benefits of astaxanthin on human subjects" · single RCT signal across all skin layers
  3. PMID 38243785 · Liu 2024 · astaxanthin fatigue / motor cross-system meta (healthy-aging context cross-link)
  4. PMID 33742704 · de Miranda 2021 · collagen peptide skin parameters meta-analysis · elasticity + hydration supported; modest wrinkle signal · 2.5–10 g/day, 8–12 wk
  5. PMID 23949208 · Proksch 2014 · foundational collagen peptide elasticity RCT · 2.5 g/day for 8 weeks
  6. PMID 17076983 · Bello 2006 · collagen hydrolysate review (broader hydrolysate · joint context cross-link)
  7. PMID 25014997 · Kawada 2014 · Nutr J · "Ingested hyaluronan moisturizes dry skin" · oral HA dry-skin moisturizing RCT
  8. PMID 28761365 · Oe 2017 · Clin Cosmet Investig Dermatol · "Oral hyaluronan relieves wrinkles" · 12-week DBPC RCT · crow's-feet wrinkle relief at 120 mg/day
  9. PMID 11340098 · Stahl 2001 · J Nutr · "Dietary tomato paste protects against ultraviolet light-induced erythema in humans" · ~16 mg lycopene/day · 10 wk · MED ~33% elevation
  10. PMID 12239422 · Stahl 2002 · Skin Pharmacol Appl Skin Physiol · carotenoids and solar UV protection review (framework cross-link)
  11. PMID 32755613 · Xia 2020 · astaxanthin cardiovascular meta-analysis (healthy-aging cross-system cross-link)

Coverage Notes

This Skin Beauty page draws from five linked ingredient pages on asxan.ai (astaxanthin, collagen peptides, oral hyaluronic acid, lycopene, tocopherols), describing each ingredient's skin evidence qualitatively in the evidence stack and treating them as mechanism candidates in How It Works. Citations on this page are verified against PubMed. Regulatory note: dietary lycopene endogenous photoprotection is NOT a topical-sunscreen substitute; anyone with diagnosed dermatologic conditions should follow a dermatologist's treatment plan.

← Home

Ask Agent Axor